相关实验视频

Updated: Sep 15, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

瘤NOS2/COX2升高促进免疫抑制表型,与ER乳腺癌的低生存率相关

Lisa A Ridnour¹, Robert Ys Cheng¹, William F Heinz²

¹Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland, USA.

|July 15, 2025

概括

瘤NOS2/COX2联合表达通过抑制免疫系统,预测ER-乳腺癌的不良结果. 向COX2可能会增强T细胞对攻击性瘤的反应.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

瘤免疫抑制严重影响患者的存活率和治疗的有效性.
瘤中NOS2和COX2的同时表达是雌激素受体阴性 (ER-) 乳腺癌预后不佳的强有力的指标.
这种共同表达驱动了瘤通过转移,耐药性,增强癌症干性和免疫逃避的进展.

研究的目的:

研究ER-瘤中NOS2/COX2表达和T效应细胞 (TEff) 透之间的空间关系.
了解NOS2和COX2对免疫抑制和糟糕的生存有所贡献的机制.
评估在临床前模型中准NOS2/COX2的治疗潜力.

主要方法:

在ER-瘤中分析NOS2,COX2,B7H4和免疫细胞 (CD3+CD8+PD1-TEff,TRegs,CD4+T细胞,巨细胞) 的空间分布.
免疫细胞格局与患者生存结果的相关性.
在4T1乳腺癌小鼠模型中,对COX2的药理抑制和NOS2的遗传缺陷.

主要成果:

NOS2/COX2和TEff细胞的独特空间景观与ER-瘤的低生存率相关.
NOS2定位在瘤边缘,而COX2和B7H4在缺乏TEff细胞的免疫沙漠地区被发现.
较高的NOS2/COX2到TEff细胞比率预测了更糟糕的结果;COX2抑制增加了CD8+TEff/TReg比率和透,与Nos2缺乏症不同.

结论:

瘤NOS2 / COX2联合表达是ER乳腺癌免疫逃避的核心,特别是通过排除CD8 + T效应细胞.
抑制COX2在克服免疫抑制和增强抗瘤免疫力方面表现有前途.
针对NOS2/COX2与免疫治疗的组合策略可能为侵袭性,耐药ER-乳腺瘤提供新的治疗途径.

关键词:

适应性免疫是一种适应性免疫.炎症炎症是一种炎症.在瘤学瘤学.在T细胞,T细胞.

更多相关视频

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...